The length of treatment with hormone therapy for prostate cancer depends on a man’s risk of recurrence, which is based on the clinical stage (the amount or spread of cancer in the body), Gleason score (system of grading prostate cancer tissue based on how it looks when examined under a microscope), and PSA level.
Hormone Therapy for Prostate Cancer. Hormone therapy is also called androgen deprivation therapy (ADT) or androgen suppression therapy. The goal is to reduce levels of male hormones, called androgens, in the body, or to stop them from affecting prostate cancer cells. Androgens stimulate prostate cancer cells to grow.
Hormone treatment is often used if prostate cancer has spread outside the prostate. It is also used if cancer remains or recurs after treatment with surgery or radiation therapy.It does not cure cancer. The purpose of hormone therapy is to delay the progression of the cancer and increase survival while maximizing quality of life.
Hormone Therapy. For this reason, hormone therapy cannot stop cancer. However, it is an important treatment in managing advanced disease and is part of the treatment regimen in most cases during recurrent or advanced prostate cancer. Hormone therapy is usually used during a time of rising PSA.
Because hormone therapy is part of the treatment of prostate cancer for nearly half of all men with the disease, and is used to treat nearly every man with advanced prostate cancer, it is important to think about ways to prevent, reverse, or identify these effects so that men can live their best lives.